glp 1 stock How GLP-1 medications are transforming diabetes and weight loss treatment The Unexpected Workplace Benefit of

July 2, 2024

Obes Rev (2020) 21(10):e13046

Exenatide (Figure 1C) exhibits relatively fast renal clearance and a short half-life (Figure 2A)

Breaking Metabolic News (and bariatric surgery barriers) Link to the press release: Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company You know, I was ALMOST done with my GLP-1 and kidney blog

Do patients regain weight after stopping GLP-1 medications

Gastrointestinal side effects from GLP-1 medications (nausea, diarrhea) can complicate absorption of oral DMARDs or mask early signs of disease flare